Table 2.
Primary problem for which ENAR was used.
| Summary of responses | ||
|---|---|---|
| Region or system involved | Count | % |
| Low back* | 111 | 25 |
| Shoulder* | 60 | 14 |
| Neck* | 56 | 13 |
| Knee* | 42 | 10 |
| Neurological | 31 | 7 |
| Ankle/foot* | 27 | 6 |
| Arthritis* | 25 | 6 |
| Fibromyalgia* | 25 | 6 |
| Hip* | 22 | 5 |
| Headache | 16 | 4 |
| Wrist/hand* | 14 | 3 |
| Thoracic spine* | 14 | 3 |
| Digestive | 13 | 3 |
| Other Head | 12 | 3 |
| Emotional | 9 | 2 |
| Elbow* | 9 | 2 |
| Skin | 8 | 2 |
| Hormonal | 6 | 1 |
| Cardiovascular | 6 | 1 |
| Genitourinary | 3 | 1 |
| General health | 2 | 0 |
Notes: a number of respondents cited more than one problem as the reason they commenced ENAR therapy. Musculoskeletal conditions are shown by ∗.